Professor Clare Sharpe, Nephrologist and Clinical Lead for the pan - London Covid 19 Kidney Clinical Advisory Group introduces the session aims.

Dr Ben Caplin, Nephrologist at Royal Free London NHS Foundation Trust shares learning from data from all London units about transmission of Covid.

Dr Caplin's research focuses on the causes, progression and complications of chronic kidney disease (CKD) with an emphasis on endemic nephropathies of unknown cause (CKDu). He is principal investigator of an ongoing cohort study investigating the causes of the epidemic of CKDu in Nicaragua. He co-chairs the international DEGREE initiative and acts as a co-investigator/international advisor on a number of studies globally, including work being conducted in Peru, Malawi, India, and Sri Lanka.

In the UK, Dr Caplin is a co-principal investigator of HEROIC, an observational study of patients with diabetic kidney disease in North and East Central London and he helped lead the analytical team undertaking the National CKD Audit for England and Wales.

Alongside population health, Dr Caplin's group uses a wide variety of molecular biological, in vivo, and clinical research techniques and aims to leverage novel technologies to gain insight into CKD and CKD-associated complications.

свернуть